Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-21-004183

VP, Corporate Controller sold 2,671 shares at an average $135.86 ($362,888)

  • VP, Corporate Controller acquired 2,433 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Goldstein Dan · VP, Corporate Controller

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-04 Exercise or conversion : show line 1 in the form +1,457 $34.21 $49,844 3,206 D
2021-02-04 Sale : show line 2 in the form −1,457 $135.84 $197,919 1,749 D
2021-02-04 Exercise or conversion : show line 3 in the form +476 $93.52 $44,516 2,225 D
2021-02-04 Sale : show line 4 in the form −476 $135.88 $64,679 1,749 D
2021-02-04 Exercise or conversion : show line 5 in the form +500 $98.03 $49,013 2,249 D
2021-02-04 Sale : show line 6 in the form −500 $135.72 $67,860 1,749 D
2021-02-04 Sale : show line 7 in the form −238 $136.26 $32,430 1,511 D
Open-market sales · 2,671 sh · avg $135.86 · $362,888

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-02-04 Exercise or conversion : show line 8 in the form Non-qualified Stock Option (Right to Buy) −1,457 0 D
2021-02-04 Exercise or conversion : show line 9 in the form Non-qualified Stock Option (Right to Buy) −476 952 D
2021-02-04 Exercise or conversion : show line 10 in the form Non-qualified Stock Option (Right to Buy) −500 1,503 D
Loading xslF345X03/form4.xml…